Blog

14 Apr

Scilex Holding Company Announces Final Postponement of Annual Meeting of Stockholders

April 14, 2023
Posted by Jitendra

PALO ALTO, CALIFORNIA – April 14, 2023 (GLOBE NEWSWIRE) - Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a subsidiary of Sorrento Therapeutics, Inc. (OTC Market: SRNEQ) (“Sorrento”), announced today that the Company’s 2023...

11 Apr

SEC FIlings

Prospectus [Rule 424(b)(3)]

April 11, 2023
Posted by Ulisses

11 Apr

SEC FIlings

Prospectus [Rule 424(b)(3)]

April 11, 2023
Posted by Ulisses

11 Apr

SEC FIlings

Prospectus [Rule 424(b)(3)]

April 11, 2023
Posted by Ulisses

11 Apr

SEC FIlings

Current report

April 11, 2023
Posted by Ulisses

10 Apr

SEC FIlings

General form for registration of securities under the Securities Act of 1933

April 10, 2023
Posted by Jitendra

05 Apr

SEC FIlings

Additional definitive proxy soliciting materials and Rule 14(a)(12)

April 5, 2023
Posted by Jitendra

05 Apr

Press Release

Scilex Holding Company Announces Postponement of Annual Meeting of Stockholders

April 5, 2023
Posted by Jitendra

PALO ALTO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company(Nasdaq: SCLX, “Scilex”), a subsidiary of Sorrento Therapeutics, Inc. (OTC Market:SRNEQ) (“Sorrento”), announced today that the Company’s 2023 Annual Meeting of...

03 Apr

SEC FIlings